Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2008-05-13
2008-05-13
Spector, Lorraine (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S158100, C530S350000, C530S388240, C530S389200, C435S370000
Reexamination Certificate
active
07371384
ABSTRACT:
ANGPTL4 compositions and methods of using such compositions, and agonists or antagonists thereof, for the diagnosis and treatment of diseases or disorders are included, including methods to modulate cell proliferation, cell adhesion, and cell migration.
REFERENCES:
patent: 5227158 (1993-07-01), Jardieu
patent: 6348350 (2002-02-01), Goddard et al.
patent: 6372491 (2002-04-01), Goddard et al.
patent: 6455496 (2002-09-01), Goddard et al.
patent: 6475753 (2002-11-01), Ruben et al.
patent: 6627741 (2003-09-01), Ruben et al.
patent: 6673545 (2004-01-01), Faris et al.
patent: 2002/0119463 (2002-08-01), Faris et al.
patent: 2003/0065151 (2003-04-01), Ruben et al.
patent: 2003/0199058 (2003-10-01), Baker et al.
patent: 2003/0207348 (2003-11-01), Shimkets et al.
patent: 2003/0207350 (2003-11-01), Baker et al.
patent: 2003/0207351 (2003-11-01), Baker et al.
patent: 2003/0207352 (2003-11-01), Baker et al.
patent: 2003/0207353 (2003-11-01), Baker et al.
patent: 2003/0207356 (2003-11-01), Baker et al.
patent: 2003/0207357 (2003-11-01), Baker et al.
patent: 2003/0207359 (2003-11-01), Baker et al.
patent: 2003/0207360 (2003-11-01), Baker et al.
patent: 2003/0207371 (2003-11-01), Baker et al.
patent: 2003/0207374 (2003-11-01), Baker et al.
patent: 2003/0207375 (2003-11-01), Baker et al.
patent: 2003/0207376 (2003-11-01), Baker et al.
patent: 2003/0207389 (2003-11-01), Baker et al.
patent: 2003/0207422 (2003-11-01), Baker et al.
patent: 2003/0207423 (2003-11-01), Baker et al.
patent: 2003/0207424 (2003-11-01), Baker et al.
patent: 2003/0207425 (2003-11-01), Baker et al.
patent: 2003/0207426 (2003-11-01), Baker et al.
patent: 2003/0207427 (2003-11-01), Baker et al.
patent: 2003/0208055 (2003-11-01), Baker et al.
patent: 2003/0215451 (2003-11-01), Ferrara et al.
patent: 2003/0219885 (2003-11-01), Baker et al.
patent: 2004/0249141 (2004-12-01), Goddard et al.
patent: 2005/0123925 (2005-06-01), Ashkenazi et al.
patent: 2005/0233361 (2005-10-01), Clerc et al.
patent: 2005/0239706 (2005-10-01), Backhed et al.
patent: 2006/0222645 (2006-10-01), Lee et al.
patent: 1315451 (2001-10-01), None
patent: 1343725 (2002-04-01), None
patent: 1 403 367 (2004-03-01), None
patent: 2000-308488 (2000-11-01), None
patent: WO 99/32515 (1999-07-01), None
patent: WO 99/45135 (1999-09-01), None
patent: WO 99/66041 (1999-12-01), None
patent: WO 99/67382 (1999-12-01), None
patent: WO 00/52165 (2000-09-01), None
patent: WO 00/61629 (2000-10-01), None
patent: WO 00/63380 (2000-10-01), None
patent: WO 01/02429 (2001-01-01), None
patent: WO 01/05825 (2001-01-01), None
patent: WO 01/05971 (2001-01-01), None
patent: WO 01/53455 (2001-07-01), None
patent: WO 01/54477 (2001-08-01), None
patent: WO 01/57188 (2001-08-01), None
patent: WO 01/77151 (2001-10-01), None
patent: WO 02/077013 (2002-10-01), None
patent: WO 02/101039 (2002-12-01), None
patent: WO 03/000865 (2003-01-01), None
patent: WO03/010205 (2003-02-01), None
patent: WO 03/025138 (2003-03-01), None
patent: WO 03/040329 (2003-05-01), None
patent: WO 03/040330 (2003-05-01), None
patent: WO 03/048185 (2003-06-01), None
patent: WO 03/060071 (2003-07-01), None
patent: WO 03/103581 (2003-12-01), None
patent: 2006014678 (2006-02-01), None
patent: 2006014729 (2006-02-01), None
patent: WO 2006/014729 (2006-02-01), None
Desai et al., Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice, Proc. Natl. Acad. Sci. USA, 104(28):11766-11771, Jul. 10, 2007.
Ge et al., Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4, J. Biol. Chem. 279(3):2038-2045, Jan. 16, 2004.
Ge Hongfei, et al., “Oligomerization and regulated proteolytic processing of angiopoietin like protein 4”Diabetes53(Suppl. 2):A576 (Jun. 2004).
Gong, Dawei et al., “New progress in adipocytokine research”Current Opinion in Endocrinology and Diabetes10(2):115-121 (2003).
Kimura, Metsutoshi et al., “Stimulation of DNA synthesis and proliferation by prostaglandins in primary cultures of adult rat hepatocytes”European Journal of Pharmacology404(3):259-271 (Sep. 2000).
Ramsay, T.G. et al., “Hormonal regulation of postnatal chicken preadipocyte differentiation in vitro”Comparative Biochemistry and PhysiologyPart B(136):245-253 (2003).
Yang, Jun et al., “Galactosylated alginate as a scaffold for hepatocytes entrapment”Biomaterials23:471-479 (2002).
Accession No. NM—020581.1, GI No. 10181163 (Accession was first seen at NCBI on Sep. 18, 2000).
Accession No. NM—139314.1, GI No. 21536397 (Accession was first seen at NCBI on Jun. 21, 2002).
Accession No. Q9BY76, GI No. 25008123 (Accession was first seen at NCBI on Nov. 15, 2002).
Accession No. Q9Z1P8, GI No. 25008127 (Accession was first seen at NCBI on Nov. 15, 2002).
Ajioka et al., “Expression of Vascular Endothelial Growth Factor Promotes Colonization, Vascularization, and Growth of Transplanted Hepatic Tissues in the Mouse”Hepatology29:396-402 (1999).
Akiyama et al., “Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux”Molecular&Cellular Biology22(8):2607-2619 (Apr. 2002).
Assy et al., “Effect of vascular edothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats”Journal of Hepatology30:911-915 (1999).
Baruch et al., “Basic fibroblast growth factor is hepatropic for rat liver in regeneration”J. Hepatol. 23:328-332 (1995).
Bouloumie et al., “Leptin, the product of Ob gene, promotes angiogenesis”Circ Res. 83(10):1059-1066 (Nov. 16, 1998).
Camenisch et al., “ANGPTL3 stimualtes endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo”J Biol Chem. 277(19):17281-17290 (May 10, 2002).
Campfield et al., “Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks”Science269:546-549 (1995).
Chehab et al., “Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin”Nat Genet. 12(3):318-320 (Mar. 1996).
Chen et al., “Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice”Cell84:491-495 (1996).
Cioffi et al., “Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction”Nature Medicine2(5):585-589 (1996).
Clement et al., “A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction”Nature392(6674):398-401 (Mar. 26, 1998).
Drakes et al., “In Vivo Administration of flt3 Ligand Markedly Stimulates Generation of Dendritic Cell Progenitors from Mouse Liver”J. Immnuol. 159:4268-4278 (1997).
Eliceiri and Cheresh, “Adhesion events in angiogenesis”Curr Opin Cell Biol. 13(5):563-568 (Oct. 2001).
Eliceiri and Cheresh, “The role of alphav integrins during angiogenesis”Mol Med. 4(12):741-750 (Dec. 1998).
Ferrara and Alitalo, “Clinical applications of angiogenic growth factors and their inhibitors”Nat Med. 5(12):1359-1364 (Dec. 1999).
Folkman and D'Amore, “Blood vessel formation: what is its molecular basis?”Cell87(7):1153-1155 (Dec. 27, 1996).
Folkman and Klagsbrun, “Angiogenic factors”Science235:442-447 (1987).
Friedlander et al., “Definition of two angiogenic pathways by distinct alpha v integrins”Science270(5241):1500-1502 (Dec. 1, 1995).
Fujiwara et al., “Stimulation of Liver Growth by Exogenous Human Hepatocyte Growth Factor in Normal and PArtially Hepatectomized Rats”Hepatol. 18:1443-1449 (1993).
Fukumura et al., “Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis”Circ Res. 93(9):e88-e97 (Oct. 31, 2003).
Gainsford et al., &
Bunting Stuart
Gerber Hanspeter
Liang Xiao Huan
Barnes Elizabeth M.
Dreger Ginger R.
Genentech Inc.
Kaufman Claire
Kresnak Mark T.
LandOfFree
Compositions and methods of using angiopoietin-like 4... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of using angiopoietin-like 4..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of using angiopoietin-like 4... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2761052